EnerplatTM
Oral Tablet
Brand Name:
EnerplatTM
Generic Name:
Eltrombopag tablet
Strength:
50mg
Description:
Oral Tablet
Pack Size:
7’s
* Storage Conditions: Do not store above 30°C temperature. Keep away from light and wet place. Keep out of reach of children. Do not freeze or shake.
FDA Approved Indications:
- For the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Eltrombopag should be used only in patients with ITP whose degree of thrombocytopenia and clinical condition increase the risk for bleeding
- For the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. Eltrombopag should be used only in patients with chronic hepatitis C whose degree of thrombocytopenia prevents the initiation of interferon-based therapy or limits the ability to maintain interferon-based therapy.
- In combination with standard immunosuppressive therapy for the first-line treatment of adult and pediatric patients 2 years and older with severe aplastic anemia.
- For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy